e-learning
resources
Paris 2018
Sunday, 16.09.2018
Biomarkers for evaluating asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prognostic value of using FeNO to guide step-down treatment decisions in asthma
K. Wang (Oxford, United Kingdom), J. Verbakel (Oxford, United Kingdom), A. Fleming-Nouri (Oxford, United Kingdom), J. Brewin (Oxford, United Kingdom), J. Oke (Oxford, United Kingdom), I. Pavord (Oxford, United Kingdom), M. Thomas (Southampton, United Kingdom)
Source:
International Congress 2018 – Biomarkers for evaluating asthma
Session:
Biomarkers for evaluating asthma
Session type:
Thematic Poster
Number:
1097
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Wang (Oxford, United Kingdom), J. Verbakel (Oxford, United Kingdom), A. Fleming-Nouri (Oxford, United Kingdom), J. Brewin (Oxford, United Kingdom), J. Oke (Oxford, United Kingdom), I. Pavord (Oxford, United Kingdom), M. Thomas (Southampton, United Kingdom). Prognostic value of using FeNO to guide step-down treatment decisions in asthma. 1097
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Predictive value of spirometry trend and FeNO for difficult to treat asthma in children
Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management
Year: 2010
FeNO testing for asthma diagnosis in primary care
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020
FeNO interpretation aid: A clinical decision support tool for interpretation of FeNO values in the patients with respiratory symptoms
Source: Annual Congress 2011 - E-learning
Year: 2011
Feasibility and acceptability of spirometry and FeNO testing in children treated for asthma in primary care
Source: International Congress 2017 – Diagnostic tools in paediatric asthma
Year: 2017
Prognostic indices for COPD patient management: how many do we need?
Source: Eur Respir J 2011; 39: 223-224
Year: 2012
Prognostic indices for COPD patient management: how many do we need?
Source: Eur Respir J 2012; 39: 223-224
Year: 2012
Optimal cut-off value and clinical usefulness of adherence starts with knowledge-12 (ASK-12) in asthmatic patients taking inhaled corticosteroid
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy?
Source: Eur Respir J 2006; 28: Suppl. 50, 319s
Year: 2006
May the value of FEV1 be helpful in the choice of the antibiotic therapy in acute exacerbation of COPD?
Source: Eur Respir J 2001; 18: Suppl. 33, 189s
Year: 2001
A comparison between the diagnostic value of bronchodilator response in spirometry and questionnaire in determining asthma
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012
The usefulness of the simultaneous measurement of IOS and FeNO in the management of asthma
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012
Suppression of
F
ENO
with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice?
Source: ERJ Open Res, 5 (4) 00123-2019; 10.1183/23120541.00123-2019
Year: 2019
Early detection of asthma exacerbations and the use of action points for treatment decisions in self-management plans
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011
Clinical utility of measuring FeNO to assess inhaled corticosteroid response in asthma.
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017
Comparison of the asthma control test and % predicted FEV1 in relation to correlation with physicians assessment of asthma control and treatment decisions
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011
Prognostic values of biomarkers in COPD
Source: Annual Congress 2013 –Natural history of COPD: novel aspects
Year: 2013
Comparative assessment of asthma control test and GINA classification in predicting asthma severity
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring II
Year: 2007
Clinical value of the immediate bronchodilator response to diagnose asthma in steroid-naïve adults
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019
Physician assessment of asthma control in patients receiving omalizumab in a real-world setting
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012
Cost-effectiveness of eNO measurements in chronic asthma management
Source: Eur Respir J 2007; 30: Suppl. 51, 193s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept